1-3 of 3
Laura Chiossone
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

IPH6501 Is a Novel NKp46-Targeting Tetraspecific Antibody-Based Natural Killer Cell Engager Therapeutic (ANKET) Armed with a Non-Alpha IL-2 Variant and Developed for the Treatment of CD20-Positive Malignancies

Olivier Demaria, Guillaume Habif, François Le Floch, Laura Chiossone, Romain Remark, Marie Vetizou, Nadia Maurel, Laurent Gauthier, Yannis Morel, Carine Paturel, Eric Vivier, Pascale Andre
Journal: Blood
Blood (2022) 140 (Supplement 1): 11559.
https://doi.org/10.1182/blood-2022-163561
Published: 2022
Journal Articles

Maturation of mouse NK cells is a 4-stage developmental program

Laura Chiossone, Julie Chaix, Nicolas Fuseri, Claude Roth, Eric Vivier, Thierry Walzer
Journal: Blood
Blood (2009) 113 (22): 5488–5496.
https://doi.org/10.1182/blood-2008-10-187179
Published: 2009
Includes: Supplemental data
Journal Articles

Molecular analysis of the methylprednisolone-mediated inhibition of NK-cell function: evidence for different susceptibility of IL-2– versus IL-15–activated NK cells

Laura Chiossone, Chiara Vitale, Francesca Cottalasso, Sara Moretti, Bruno Azzarone, Lorenzo Moretta, Maria Cristina Mingari
Journal: Blood
Blood (2007) 109 (9): 3767–3775.
https://doi.org/10.1182/blood-2006-07-037846
Published: 2007
Includes: Supplemental data